|
Contents: |
CONTACT DETAILS
TABLE OF CONTENTS
EXECUTIVE SUMMARY
INTRODUCTION
CARDIOVASCULAR RISK FACTORS
Introduction
Anti-hypertensives
Anti-dyslipidemics
THROMBOSIS
CARDIOVASCULAR DYSFUNCTION
Heart failure
Arrhythmia
Atherosclerosis
Angina pectoris
Gene therapy
MAJOR PLAYERS
COMPANY PROFILES
Merck & Co.
Pfizer
Bristol-Myers Squibb (BMS)
Novartis
AstraZeneca
Conclusion
REFERENCES
Bibliography
Internet resources
Datamonitor resources
List of figures
|
|